162 related articles for article (PubMed ID: 10213160)
1. Insulin-degrading enzyme in the Alzheimer's disease brain: prominent localization in neurons and senile plaques.
Bernstein HG; Ansorge S; Riederer P; Reiser M; Frölich L; Bogerts B
Neurosci Lett; 1999 Mar; 263(2-3):161-4. PubMed ID: 10213160
[TBL] [Abstract][Full Text] [Related]
2. Differential cerebral deposition of IDE and NEP in sporadic and familial Alzheimer's disease.
Dorfman VB; Pasquini L; Riudavets M; López-Costa JJ; Villegas A; Troncoso JC; Lopera F; Castaño EM; Morelli L
Neurobiol Aging; 2010 Oct; 31(10):1743-57. PubMed ID: 19019493
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of Insulin-degrading Enzyme in Alzheimer's Disease: A Meta-Analysis.
Zhang H; Liu D; Huang H; Zhao Y; Zhou H
Curr Alzheimer Res; 2018; 15(7):610-617. PubMed ID: 29357797
[TBL] [Abstract][Full Text] [Related]
4. Insulin-degrading enzyme as a downstream target of insulin receptor signaling cascade: implications for Alzheimer's disease intervention.
Zhao L; Teter B; Morihara T; Lim GP; Ambegaokar SS; Ubeda OJ; Frautschy SA; Cole GM
J Neurosci; 2004 Dec; 24(49):11120-6. PubMed ID: 15590928
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of MET in hippocampal neurons of Alzheimer's disease brains.
Hamasaki H; Honda H; Suzuki SO; Hokama M; Kiyohara Y; Nakabeppu Y; Iwaki T
Neuropathology; 2014 Jun; 34(3):284-90. PubMed ID: 24444253
[TBL] [Abstract][Full Text] [Related]
6. Dipeptidyl peptidase IV, which probably plays important roles in Alzheimer disease (AD) pathology, is upregulated in AD brain neurons and associates with amyloid plaques.
Bernstein HG; Dobrowolny H; Keilhoff G; Steiner J
Neurochem Int; 2018 Mar; 114():55-57. PubMed ID: 29353063
[TBL] [Abstract][Full Text] [Related]
7. [Cerebral proteolysis of amiloid-b peptide: relevance of insulin-degrading enzyme in Alzheimer's disease].
Leal MC; Fernandez Gamba A; Morelli L; Castaño EM
Medicina (B Aires); 2009; 69(4):466-72. PubMed ID: 19770104
[TBL] [Abstract][Full Text] [Related]
8. Neuronal expression of glutamine synthetase in Alzheimer's disease indicates a profound impairment of metabolic interactions with astrocytes.
Robinson SR
Neurochem Int; 2000 Apr; 36(4-5):471-82. PubMed ID: 10733015
[TBL] [Abstract][Full Text] [Related]
9. Caspase-cleaved amyloid precursor protein in Alzheimer's disease.
Ayala-Grosso C; Ng G; Roy S; Robertson GS
Brain Pathol; 2002 Oct; 12(4):430-41. PubMed ID: 12408229
[TBL] [Abstract][Full Text] [Related]
10. Neuronal localization of the TNFalpha converting enzyme (TACE) in brain tissue and its correlation to amyloid plaques.
Skovronsky DM; Fath S; Lee VM; Milla ME
J Neurobiol; 2001 Oct; 49(1):40-6. PubMed ID: 11536196
[TBL] [Abstract][Full Text] [Related]
11. Activated caspase-3 expression in Alzheimer's and aged control brain: correlation with Alzheimer pathology.
Su JH; Zhao M; Anderson AJ; Srinivasan A; Cotman CW
Brain Res; 2001 Apr; 898(2):350-7. PubMed ID: 11306022
[TBL] [Abstract][Full Text] [Related]
12. Bleomycin hydrolase immunoreactivity in senile plaque in the brains of patients with Alzheimer's disease.
Namba Y; Ouchi Y; Takeda A; Ueki A; Ikeda K
Brain Res; 1999 May; 830(1):200-2. PubMed ID: 10350576
[TBL] [Abstract][Full Text] [Related]
13. Effect of Tong Luo Jiu Nao on Aβ-degrading enzymes in AD rat brains.
Liu Y; Hua Q; Lei H; Li P
J Ethnopharmacol; 2011 Sep; 137(2):1035-46. PubMed ID: 21798326
[TBL] [Abstract][Full Text] [Related]
14. Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer's disease is associated with the apolipoprotein E-epsilon4 allele.
Cook DG; Leverenz JB; McMillan PJ; Kulstad JJ; Ericksen S; Roth RA; Schellenberg GD; Jin LW; Kovacina KS; Craft S
Am J Pathol; 2003 Jan; 162(1):313-9. PubMed ID: 12507914
[TBL] [Abstract][Full Text] [Related]
15. Impact of Insulin Degrading Enzyme and Neprilysin in Alzheimer's Disease Biology: Characterization of Putative Cognates for Therapeutic Applications.
Jha NK; Jha SK; Kumar D; Kejriwal N; Sharma R; Ambasta RK; Kumar P
J Alzheimers Dis; 2015; 48(4):891-917. PubMed ID: 26444774
[TBL] [Abstract][Full Text] [Related]
16. Sequence variants of IDE are associated with the extent of beta-amyloid deposition in the Alzheimer's disease brain.
Blomqvist ME; Chalmers K; Andreasen N; Bogdanovic N; Wilcock GK; Cairns NJ; Feuk L; Brookes AJ; Love S; Blennow K; Kehoe PG; Prince JA
Neurobiol Aging; 2005 Jun; 26(6):795-802. PubMed ID: 15718037
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical analysis of hippocampal butyrylcholinesterase: Implications for regional vulnerability in Alzheimer's disease.
Mizukami K; Akatsu H; Abrahamson EE; Mi Z; Ikonomovic MD
Neuropathology; 2016 Apr; 36(2):135-45. PubMed ID: 26293308
[TBL] [Abstract][Full Text] [Related]
18. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo.
Farris W; Mansourian S; Chang Y; Lindsley L; Eckman EA; Frosch MP; Eckman CB; Tanzi RE; Selkoe DJ; Guenette S
Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4162-7. PubMed ID: 12634421
[TBL] [Abstract][Full Text] [Related]
19. Na,K-ATPase mRNA levels and plaque load in Alzheimer's disease.
Chauhan NB; Lee JM; Siegel GJ
J Mol Neurosci; 1997 Dec; 9(3):151-66. PubMed ID: 9481617
[TBL] [Abstract][Full Text] [Related]
20. Changes in the cellular distribution of glutamine synthetase in Alzheimer's disease.
Robinson SR
J Neurosci Res; 2001 Dec; 66(5):972-80. PubMed ID: 11746426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
